The Global Carrier Screening Market Size is Expected to Grow From USD 1.8 Billion in 2019 to USD 4.0 Billion by 2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 20, 2019--
The “Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.
The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period.
Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market.
Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection and prevention, the high risk of chromosomal abnormalities, and technological advancements in carrier screening, such as the introduction of expanded carrier screening panels. The increasing awareness of carrier screening is expected to provide a wide range of growth opportunities for players in the market.
The expanded carrier screening segment is expected to grow at the highest CAGR during the forecast period.
On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening, which includes predesigned and customized carrier screening panel testing. The growth of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & microarrays and recommendations for the use of expanded carrier screening.
In 2018, the hospitals segment accounted for the largest share of the carrier screening market.
On the basis of end-user, the carrier screening market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users (blood banks, donor banks, community clinic laboratories, and non-profit organizations). In 2018, hospitals formed the largest end-user segment in the carrier screening market. Generally, gynecologists suggest couples to undergo carrier screening tests before and after pregnancy. In such cases, it is observed that gynecologists give reference for genetic counselors, who generally practice at hospitals. As a result, the awareness about hospital-based carrier screening tests is higher among patients than those offered at reference laboratories or at physician offices and clinics. Also, hospitals offer flexibility to patients in terms of sample collection, scheduling specimen pickups, and rapid turnaround time to produce results.
North America to grow at the highest CAGR during the forecast period.
North America is expected to grow at the highest rate during the forecast period, followed by Europe. This growth can be attributed to several factors, such as the presence of well-established healthcare systems in the US and Canada, wide access to advanced screening techniques (such as DNA sequencing), recommendations for carrier screening, high and growing demand for the early detection of genetic disorders among the population, availability of mass genetic testing programs, increasing number of awareness campaigns, and the high incidence of chromosomal disorders.
Key Topics Covered:
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Years Covered for the Study
2 Research Methodology
2.1 Research Data
2.2 Market Estimation Methodology
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary
4 Premium Insights
4.1 Market Overview
4.2 Europe: Market Share, By Type and Country (2019)
4.3 Market, By Medical Condition
4.4 Market, By Technology (USD Million) (2019 vs 2024)
4.5 Market, By End User (USD Million) (2019 vs 2024)
5 Market Overview
5.2 Market Dynamics
6 Carrier Screening Market, By Product & Service
7 Carrier Screening Market, By Type
7.2 Expanded Carrier Screening
7.3 Targeted Disease Carrier Screening
8 Carrier Screening Market, By Medical Condition
8.2 Pulmonary Conditions
8.3 Hematological Conditions
8.4 Neurological Conditions
8.5 Other Medical Conditions
9 Carrier Screening Market, By Technology
9.2 Dna Sequencing
9.3 Polymerase Chain Reaction
9.5 Other Technologies
10 Carrier Screening Market, By End User
10.3 Reference Laboratories
10.4 Physician Offices and Clinics
10.5 Other End Users
11 Carrier Screening Market, By Region
11.2 North America
11.4 Asia Pacific
12 Competitive Landscape
12.2 Market Ranking Analysis
12.3 Competitive Leadership Mapping (2019)
12.4 Competitive Scenario
13 Company Profile
13.1 Eurofins Scientific
13.2 Invitae Corporation
13.3 Opko Health
13.4 Fulgent Genetics Inc
13.5 Quest Diagnostics Incorporated
13.7 Myriad Genetics
13.8 Illumina Inc
13.9 Thermo Fisher Scientific Inc
13.10 Luminex Corporation
13.11 Natera Inc
13.12 Laboratory Corporation of America Holdings
13.14 Gene By Gene
13.16 Otogenetics Corporation
13.18 Pathway Genomics
13.20 True Health
For more information about this report visit https://www.researchandmarkets.com/r/clwz04
View source version on businesswire.com:https://www.businesswire.com/news/home/20191120005414/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/20/2019 06:40 AM/DISC: 11/20/2019 06:40 AM